Cargando…
Is It Possible to Predict Respiratory Evolution in COVID-19 Patients?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254280/ https://www.ncbi.nlm.nih.gov/pubmed/35580562 http://dx.doi.org/10.1159/000524043 |
| _version_ | 1784740661955657728 |
|---|---|
| author | Barbas, Carmen Silvia Valente Mazza, Bruno Franco |
| author_facet | Barbas, Carmen Silvia Valente Mazza, Bruno Franco |
| author_sort | Barbas, Carmen Silvia Valente |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9254280 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | S. Karger AG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92542802022-09-23 Is It Possible to Predict Respiratory Evolution in COVID-19 Patients? Barbas, Carmen Silvia Valente Mazza, Bruno Franco Respiration Editorial Comment S. Karger AG 2022-07 2022-05-17 /pmc/articles/PMC9254280/ /pubmed/35580562 http://dx.doi.org/10.1159/000524043 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
| spellingShingle | Editorial Comment Barbas, Carmen Silvia Valente Mazza, Bruno Franco Is It Possible to Predict Respiratory Evolution in COVID-19 Patients? |
| title | Is It Possible to Predict Respiratory Evolution in COVID-19 Patients? |
| title_full | Is It Possible to Predict Respiratory Evolution in COVID-19 Patients? |
| title_fullStr | Is It Possible to Predict Respiratory Evolution in COVID-19 Patients? |
| title_full_unstemmed | Is It Possible to Predict Respiratory Evolution in COVID-19 Patients? |
| title_short | Is It Possible to Predict Respiratory Evolution in COVID-19 Patients? |
| title_sort | is it possible to predict respiratory evolution in covid-19 patients? |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254280/ https://www.ncbi.nlm.nih.gov/pubmed/35580562 http://dx.doi.org/10.1159/000524043 |
| work_keys_str_mv | AT barbascarmensilviavalente isitpossibletopredictrespiratoryevolutionincovid19patients AT mazzabrunofranco isitpossibletopredictrespiratoryevolutionincovid19patients |